AVNS (Avanos Medical) Total Debt per Share: $2.97 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AVNS Avanos Medical Inc AVNS
40 GF Score
Price $24.99
GF Value $19.34
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Avanos Medical Total Debt per Share?

Avanos Medical AVNS +0.04% 40 Total Debt per Share is $2.97 as of Mar. 2026. GuruFocus rates AVNS with a GF Score™ of 40/100 and a GF Value™ of $19.34 (Modestly Overvalued). The stock has 5 warning signs investors should review.

$2.97 (As of Mar. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Avanos Medical's Total Debt Per Share for the quarter that ended in Mar. 2026 was $2.97.


Avanos Medical Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Avanos Medical's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avanos Medical Total Debt per Share Chart

Avanos Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.89 5.95 4.53 3.70 2.78

Avanos Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.05 2.97 2.88 2.78 2.97
AVNS
40GF Score
Avanos Medical Inc AVNS
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avanos Medical Total Debt per Share Calculation

Avanos Medical's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Avanos Medical's Total Debt Per Share for the quarter that ended in Mar. 2026 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of $2.97 mean?
Avanos Medical (AVNS) has a Total Debt per Share of $2.97 as of Mar. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Avanos Medical and its competitors.
Is Avanos Medical's Total Debt per Share too high?
Avanos Medical's current Total Debt per Share is $2.97. Overall, Avanos Medical has a GF Score™ of 40/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's Total Debt per Share compare to TNDM and IRMD?
Avanos Medical's Total Debt per Share of $2.97 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Medical Devices & Instruments company?
A good Total Debt per Share depends on the Medical Devices & Instruments industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Avanos Medical and its competitors. Avanos Medical's current Total Debt per Share is $2.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.34, compared to a current price of $24.99 — trading 29.2% above its estimated fair value. The current Total Debt per Share is $2.97. Avanos Medical's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Avanos Medical (AVNS), the current Total Debt per Share is $2.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Avanos Medical (AVNS) Overvalued in 2026?

Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued. The current stock price of $24.99 is trading 29.2% above its estimated GF Value™ of $19.34. GuruFocus considers Avanos Medical to be Modestly Overvalued.

Key valuation signals for AVNS:

  • Total Debt per Share: $2.97
  • GF Value™: $19.34 vs. price of $24.99 (29.2% above fair value)
  • GF Score™: 40/100 with 5 warning signs

No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Avanos Medical Business Description

Other Exchanges 8HH:Germany
Address 5405 Windward Parkway, Suite 100 South, Alpharetta, GA, USA, 30004
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
40GF Score

Get the complete analysis for AVNS

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.99
Price
$19.34
GF Value